SF 400 reclassifies misoprostol, mifepristone, and methotrexate as Schedule III controlled substances in Iowa. This means anyone who manufactures, distributes, or dispenses these medications would face a class C felony charge, with fines between $1,000 and $50,000. The bill directly affects healthcare providers who prescribe or dispense these specific medications, which are commonly used for medical abortions and other treatments. The policy change would significantly restrict access to these drugs by imposing criminal penalties on their distribution. The bill is currently in the Judiciary committee subcommittee for review.
This bill prohibits administering gene-based vaccines in Iowa, defined as vaccines using mRNA, modified mRNA, self-amplifying mRNA, or DNA technology. Violators face a $500 fine per incident and potential license review by health licensing boards for professionals licensed under Iowa's health professions code (Chapter 147). It directly affects healthcare providers who administer such vaccines, including doctors, nurses, and pharmacists. The law creates a clear legal restriction on the use of these specific vaccine technologies within the state.
HF 712 requires vaccine manufacturers to waive legal protection under federal law (42 U.S.C. §300aa-1 et seq.) before distributing, selling, or administering vaccines in Iowa. This bill directly affects vaccine manufacturers operating in Iowa, as they must affirmatively give up immunity from lawsuits for injuries caused by vaccine design defects. The key mechanism is a mandatory waiver: if a vaccine is distributed in Iowa, the manufacturer is deemed to have waived federal immunity for design defect claims, overriding the National Childhood Vaccine Injury Act. The bill does not change liability for other vaccine issues like manufacturing errors.
HF 571, the "Medical Ethics Defense Act," protects medical practitioners, healthcare institutions, and health care payors from discrimination when refusing to provide or cover specific services based on conscience (e.g., religious or ethical beliefs). It prohibits adverse actions like termination or penalties for such refusals, requires health care payors to cover services they’re contractually obligated to pay for, and grants immunity from liability for good-faith conscience-based decisions. The bill also shields whistleblowers who report violations related to conscience protections or ethical violations to authorities like the attorney general or federal agencies. It explicitly does not override requirements for emergency care under federal law.
SF 220, the "Medical Ethics Defense Act," protects medical practitioners (including doctors and nurses), health care institutions (like hospitals), and health care payors (such as insurance companies) from discrimination when they refuse to provide specific health care services based on their ethical, moral, or religious beliefs. The bill prohibits retaliation, including penalties or disciplinary actions, for such refusals and grants legal immunity from civil, criminal, or administrative liability. It also shields individuals who report violations of these protections to authorities like the attorney general or federal agencies. However, the law does not override the requirement for health care institutions to provide emergency medical services.
HF 972, now law after Governor's signature on May 28, 2025, establishes a new funding model for Iowa's rural healthcare systems while eliminating several existing health care programs. It removes specific award, grant, residency, and fellowship programs, and creates a new incentive program to attract healthcare professionals to underserved areas. The bill also modifies Medicaid funding for graduate medical education, updates the Health Facilities Council, and addresses the Iowa Health Information Network, with all changes including necessary funding appropriations. These changes directly affect rural health providers, medical training programs, and state health agencies managing these systems.
